Do older adults using NSAIDs have a reduced risk of colorectal cancer?

Michael Hoffmeister1, Jenny Chang-Claude, Hermann Brenner

  • 1Department of Epidemiology, German Centre for Research on Ageing (DZFA), Heidelberg, Germany.

Drugs & Aging
|July 29, 2006
PubMed
Abstract

Insights

Long-term nonsteroidal anti-inflammatory drug (NSAID) use appears to reduce colorectal cancer (CRC) risk in older adults, similar to younger populations. However, initiating NSAID use in old age for CRC prevention requires further study due to potential risks.

Area of Science:

  • Gerontology
  • Gastroenterology
  • Oncology

Background:

  • Colorectal cancer (CRC) predominantly affects older adults.
  • Nonsteroidal anti-inflammatory drug (NSAID) use is common in the elderly, but its impact on CRC risk in this age group is not well understood.

Purpose of the Study:

  • To review current evidence on the effects of NSAID use on CRC risk in individuals aged 65 years and older.
  • To assess the impact of long-term NSAID use on CRC risk in the elderly population.

Main Methods:

  • Searched PubMed for articles published before August 2005.
  • Included studies with subgroup analyses of individuals aged 65+ or investigating long-term NSAID use (≥5 years) and CRC risk.
  • Extracted and compared relevant information on sample characteristics and CRC risk association.

Main Results:

  • Identified 19 studies; only four specifically analyzed NSAID use in individuals aged 65+.
  • Two of these four studies showed CRC risk reduction comparable to younger age groups.
  • Observational studies indicated decreasing CRC risk with increasing NSAID duration, suggesting significant reduction after 10-20 years of regular use.

Conclusions:

  • Available data suggest NSAID use may reduce CRC risk in the elderly, comparable to other age groups.
  • The effectiveness of initiating NSAID use for CRC prevention in advanced age remains unknown.
  • More research is needed on optimal NSAID dosage and duration for older adults, considering potential adverse effects like cardiovascular outcomes.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...